Jiangxi Rimag Group (HKG:2522) is looking to raise net proceeds of up to HK$182.3 million from the placement of 9,750,000 shares to at least six investors at HK$20 apiece, a Friday filing with the Hong Kong bourse said.
The shares represent approximately 3.76% of issued H shares and 2.66% of the total number of issued shares as enlarged by the issue.
The medical imaging solution services company will use proceeds from the issue for business investment and mergers and acquisitions, overseas business expansion, data and R&D, and general working capital.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.